A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.
about
Essential role of miRNAs in orchestrating the biology of the tumor microenvironmentRecent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerBlockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.Histone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals.Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth.Role of CD11b+Gr-1+ myeloid cells in AGEs-induced myocardial injury in a mice model of acute myocardial infarction.CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.Didymin reverses phthalate ester-associated breast cancer aggravation in the breast cancer tumor microenvironmentNeutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment.The clinical impact of ICOS signal in colorectal cancer patientsCCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse BrainMyeloid-derived suppressor cells in breast cancer.microRNA-mediated regulation of the tumor microenvironment.Harnessing the immune system for the treatment of breast cancer.The inflammatory chemokine CCL5 and cancer progressionBlockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancer-associated fibroblast accumulation.Suppressive role of myeloid-derived suppressor cells (MDSCs) in the microenvironment of breast cancer and targeted immunotherapies.The tumor microenvironment: a pitch for multiple players.microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.Breast cancer stem cells and the immune system: promotion, evasion and therapy.Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.CCR5 in recruitment and activation of myeloid-derived suppressor cells in melanoma.Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway.A single neonatal administration of Bisphenol A induces higher tumour weight associated to changes in tumour microenvironment in the adulthood.CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.Annexin-A1 enhances breast cancer growth and migration by promoting alternative macrophage polarization in the tumour microenvironment.Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.Chemokine (C-C Motif) Ligand 5 is Involved in Tumor-Associated Dendritic Cell-Mediated Colon Cancer Progression Through Non-Coding RNA MALAT-1.Tolerogenic Transcriptional Signatures of Steady-State and Pathogen-Induced Dendritic Cells.Effect of CCL5 expression in the recruitment of immune cells in triple negative breast cancer.CCL5-deficiency enhances intratumoral infiltration of CD8+ T cells in colorectal cancer.
P2860
Q26745667-94C98087-89DC-497C-A7C3-7565BCC299F3Q26784324-43C9E1E9-3898-4AB0-9D7C-D999606EDB33Q33676412-8335A02C-A530-4A19-9F42-0E2262454382Q34101036-6C825869-7453-4D80-BAE4-E696AA71F869Q35145319-A41ABC02-0893-43C4-B6CD-678151937C3BQ35632399-137EC780-4489-4B04-9AD8-5E3152D50C13Q35742418-A9247101-BEBA-4667-A10C-3D7CE87C35DEQ36309612-929154D7-FA2D-407E-A807-0E686DA1AE40Q36524400-29FB22C6-4B34-42E4-88A1-B78029A09980Q36895360-2AE29136-B9BB-4208-A332-53C9AD63ADE9Q37012600-3F1F36F9-0D0F-4C4F-9A03-B5644BAB3A90Q37058153-676E8D71-978A-4B53-ACCD-6FE2D3CD7B2DQ37096574-0BB3163B-C421-45D7-AB75-322C428A534EQ37172813-799C0959-39E4-47A2-9014-90862493C5BEQ37452957-2E98E94E-2CA3-49E6-9749-0BFB01C648D2Q37476039-0D7C3366-6287-4CD1-9BD6-D38B0A66AB89Q37541911-7B7E6A89-3324-4F8B-B76B-3748F6A8E010Q37565466-222D9294-CFF6-499F-AC4F-D0BA19F2E5E9Q37665711-C6756B91-FDB6-4306-BEEF-E875EC3B9E9BQ38101567-4F8FA5F6-9B13-4AB0-9FBE-4E01E7015530Q38213075-90DAD5FF-5E8B-4075-B700-964EEB196ECBQ38226597-B57EB0F4-B8CF-470B-A142-EB5F97BB94D1Q38336989-7242F073-6DE0-432E-8454-FB4756B02DD9Q39223523-FB5018C3-0F35-4D96-ABF6-25B647B725EFQ41082417-86736C42-8FC5-4749-BC8C-42516D694DE9Q41620366-07D11767-1223-43BE-AD8E-14EBF5EB7195Q47144882-FB939A69-F156-4659-91CB-FCFE4ED2EDC4Q47158605-625BE960-E59E-4AFA-83AC-67F79E244851Q47399839-13DED6C2-4D44-4DC5-883C-3BA605E0612CQ50443511-F0D035E5-E015-41BF-B894-96BA63F2019AQ52979689-447E0294-0ECE-4950-9B50-FCF2A8280EC1Q54255767-9FA9299B-F041-492E-916A-C0F4FA530D29Q55238772-7CE184D3-A0F3-4712-B2E2-9262190A8119Q55534075-5EF9297C-E0C1-483F-834D-A51E972BA882
P2860
A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A novel role of hematopoietic ...... loid-derived suppressor cells.
@ast
A novel role of hematopoietic ...... loid-derived suppressor cells.
@en
type
label
A novel role of hematopoietic ...... loid-derived suppressor cells.
@ast
A novel role of hematopoietic ...... loid-derived suppressor cells.
@en
prefLabel
A novel role of hematopoietic ...... loid-derived suppressor cells.
@ast
A novel role of hematopoietic ...... loid-derived suppressor cells.
@en
P2093
P2860
P356
P1433
P1476
A novel role of hematopoietic ...... loid-derived suppressor cells.
@en
P2093
Ha-Jeong Kim
Robert A Kurt
Xiaojing Ma
P2860
P2888
P304
P356
10.1038/CR.2012.178
P577
2012-12-25T00:00:00Z